FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
): FDA approved the first generic referencing Victoza, indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type